Lynntech

The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.

A former scientist from Texas-based R&D firm Lynntech who was developing a nucleic acid sample prep module intended for use with molecular diagnostic assays for resource-poor areas of the world has left the company and founded his own startup to commercialize an improved vers

The grants, awarded through the Qualifying Therapeutic Discovery Project Program created by the Patient Protection and Affordable Care Act of 2010, were disclosed last week by the IRS.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.